Electromedical Technologies, Inc.
EMED
$0.0002
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -86.87% | -19.46% | -23.35% | -16.90% | 15.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -86.87% | -19.46% | -23.35% | -16.90% | 15.74% |
| Cost of Revenue | -83.56% | 3.04% | -16.88% | -10.53% | 24.83% |
| Gross Profit | -87.82% | -25.43% | -25.29% | -18.62% | 13.41% |
| SG&A Expenses | -7.06% | -17.04% | -74.84% | 3.30% | -19.56% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -44.85% | -50.23% | -24.04% | -7.43% | 46.78% |
| Total Operating Expenses | -24.71% | -23.08% | -72.86% | -15.56% | -8.80% |
| Operating Income | -59.41% | 26.24% | 87.72% | 13.33% | 29.16% |
| Income Before Tax | -92.35% | 115.84% | -83.36% | 57.99% | 60.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -92.35% | 115.84% | -83.36% | 57.99% | 60.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -92.35% | 115.84% | -83.36% | 57.99% | 60.67% |
| EBIT | -59.41% | 26.24% | 87.72% | 13.33% | 29.16% |
| EBITDA | -58.95% | 26.57% | 87.77% | 11.47% | 27.99% |
| EPS Basic | -37.50% | 109.09% | 5.26% | 83.67% | 88.06% |
| Normalized Basic EPS | -40.00% | 111.11% | 74.42% | 73.68% | 76.19% |
| EPS Diluted | -37.50% | 102.27% | 5.26% | 89.19% | 88.06% |
| Normalized Diluted EPS | -40.00% | 103.70% | 74.42% | 73.68% | 76.19% |
| Average Basic Shares Outstanding | 46.07% | 69.15% | 93.22% | 165.50% | 217.17% |
| Average Diluted Shares Outstanding | 46.07% | 479.31% | 93.22% | 165.50% | 217.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
